We evaluated the feasibility of robot-assisted laparoscopic radical cystectomy (RARC) with pelvic lymph node dissection (PLND), especially extended PLND (ePLND), during our initial experience with this technique. Materials and Methods: From August 2007 to March 2009, prospective data were obtained from the 21 consecutive patients who underwent RARC with PLND at Korea University Hospital. Data included baseline characteristics, perioperative variables, pathological outcomes, and complications. Evidence of the lymph node yield curve was examined by using linear regression to compare the number of lymph nodes obtained. Results: Among 21 patients who underwent RARC, 13 had ileal conduit urinary diversion and 8 had orthotopic neobladder. Standard PLND (sPLND) was performed in the first 15 patients, and ePLND was performed in the more recent 6 patients. The mean total operative time was 515.5±145.1 minutes, and the mean estimated blood loss was 346.8±205.9 ml. The mean time for PLND was 106.7±25.2 minutes in patients with ePLND and 72.1±14.1 minutes in patients with sPLND (p=0.001). All patients had negative surgical margins. The mean number of retrieved nodes was 23. 5±12.8 (range, 8-50) 
INTRODUCTION
Radical cystectomy is the gold standard option for patients with muscle-invasive bladder cancer and for those with recurrent, high-grade non-muscle-invasive bladder cancer [1] .
About 25% of patients have lymph node metastasis according to pathologic evidence at the time of radical cystectomy, although preoperative evaluation does not show metastatic lymphadenopathy [2] . In that aspect, it has been suggested that pelvic lymph node dissection (PLND) has an important role in disease staging and a therapeutic or even curative effect in selected patients. Herr described that survival was improved regardless of positivity of lymph node metastasis when a higher number of lymph nodes were removed [3] . Leissner et al reported that the disease-free interval was increased with more lymph nodes retrieved, regardless of the presence or absence of lymph node metastases [4] . In an attempt to maximize lymph node removal during radical cystectomy, the extent of pelvic lymphadenectomy has been questioned. Poulsen et al reported an improved 5-year recurrence-free survival with extended PLND (ePLND) beginning at the bifurcation of the aorta and including the common and external iliac vessels, presacral nodes, and obturator fossa [5] . The introduction of laparoscopy in urology has been expanding in the field of PLND. In 1991, Schuessler et al reported the first laparoscopic PLND for prostate cancer, which was safe and feasible [6] . Finelli et al reported that laparoscopic pelvic lymphadenectomy for bladder cancer was feasible and efficient [7] , but laparoscopic procedures have prolonged operative times, significant technical difficulties, and a difficult learning curve [8] .
Recently, a robot-assisted laparoscopic technique has emerged that allows surgeons to more readily overcome the difficult learning curve. The robot-assisted laparoscopic surgical system has a 3-dimensional imaging system and the patented Endowrist Ⓡ technology to enable meticulous dissection and easy handling of laparoscopic instruments. Robot assistance reduces the difficulty in performing laparoscopic procedures, particularly in comparison with pure laparoscopic pelvic surgery. The robot-assisted laparoscopic technique has been applied to pelvic lymphadenectomy. Woods et al reported that robotic ePLND was safe and feasible in the management of bladder cancer [9] . Guru et al also reported that robot-assisted PLND was safe and lymph node yield was oncologically acceptable [10] .
To our knowledge, however, there has been no report on the feasibility and efficiency of robot-assisted laparoscopic pelvic lymphadenectomy in Korea. Herein we prospectively evaluate whether robot-assisted laparoscopic pelvic lymphadenectomy can be performed without compromising morbidity and mortality during radical cystectomy, especially ePLND. 
MATERIALS AND METHODS

Patients and parameters
Techniques of the operation
All of the operations were performed by a single surgeon were the obturator nerve posteriorly, the genitofemoral nerve laterally, the common iliac vessels proximally, and the node of Cloquet distally. sPLND was performed technically in the same way as ePLND. ePLND was performed during the late phase of this study, whereas sPLND was during the initial phase.
RARC was performed after the PLND was completed. All urinary diversions were created extracorporeally, and the neovesicourethral anastomoses were robotically performed with redocking of the robotic instruments.
RESULTS
Baseline characteristics and perioperative data
Of the 21 patients, 20 patients were male and 1 was female.
The mean age of all patients was 61. Table 4 . Pathologic outcomes Fig. 3 . Lymph node yield (LNY) curve: The patients in the extended pelvic lymph node dissection (ePLND) group had a larger LNY than did the patients in the standard PLND group. and 38.6 (29-50) in patients with ePLND (p=0.001) ( Table 4) .
As operative experience increased, the LNY for all patients improved with no significant increase in operative duration (p= 0.008) (Fig. 3) . The LNY also especially improved, as operative cases increased, for ePLND cases (p=0.005) (Fig. 3) . The correlation between the number of cases and LNY was very strong (rho=0.943). Three patients had positive LNs retrieved by sPLND. The mean postoperative follow-up periods were 8.9
months (1-21), and one patient with LN metastasis died from lung metastasis of bladder cancer. The overall survival rate was 95.2% (20 of 21 patients), and the disease-specific survival rate was also 95.2%.
DISCUSSION
The initial reports on the role of PLND were from poor outcomes of patients with local pelvic recurrence after simple cystectomy [13] . Colston and Leadbetter reported a cadaveric study and found that 25% had metastatic disease localized to the lymphatic tissue of the pelvis and retroperitoneum [14] .
Whitmore and Marshall reported that a survival benefit was possible when lymphadenectomy was combined with cystectomy [15] . Lymphadenectomy during radical cystectomy might serve both a diagnostic and a therapeutic purpose. Despite the development of imaging techniques, however, the significant lack of accuracy and the discrepancy between clinical and pathologic staging is evident [16, 17] . To overcome these limitations, several new techniques, such as positron emission tomography (PET), single photon emission computed tomography (SPECT), etc, are currently being studied [18, 19] . In one multicenter study [21] , the mean total number of LNs removed was 43.1 by ePLND. Poulsen et al reported that more
LNs were removed in extended dissection (25 LNs versus 14
LNs in standard dissection) [5] . Bochner et al confirmed these findings, reporting a significantly greater number of nodes removed with an extended dissection when compared with a more standard dissection, that is, 36.5 versus 8.5, respectively [22] . The way a specimen is submitted for pathologic assessment also affects LN yield. Bochner et al reported that to facilitate nodal evaluation, separate nodal packets should be submitted intraoperatively by the urologists [22] . In our study, the extents of ePLND were the hypogastric nerve posteriorly, the genitofemoral nerve laterally, the inferior mesenteric artery and common iliac vessels proximally, and the circumflex vein and the node of Cloquet distally. This followed the trend in currently performed lymphadenectomy [10] . We also used separate LN packets, instead of the en bloc method of LN submission. The 3 packets in the standard procedure included Although ePLND may have beneficial effects on tumor treatment, the risks for morbidity and mortality associated with ePLND must be carefully evaluated. The extended procedure has been shown to increase operative duration by 1 to 1.5 hours compared with the standard procedure [7, 25] . Brossner et al analyzed whether the morbidity from radical cystectomy increased with ePLND [26] . The patients in the ePLND group had an operation time that was around 60 minutes longer than that for patients in the sPLND group. However, no significant differences were found in perioperative morbidity, early com- in the sPLND group and 3 patients (50%) in the ePLND group.
The minor complications included cases of prolonged ileus, acute renal failure, postoperative delirium, and leakage of urethral anastomosis (Table 3) .
Minimally invasive surgery is now beginning to gain acceptance as a viable alternative to selected open oncological procedures in urology [27] . There are several reports on the safety and efficacy of laparoscopic PLND and radical cystectomy. Haber and Gill reported the results of 37 patients who underwent laparoscopic PLND with radical cystectomy [28] .
Limited PLND was used in the initial 11 patients, with a median yield of 6 nodes, whereas ePLND was used in the subsequent 26 patients, with an increased median yield of 21 nodes. Overall survival was better when ePLND was used (76% vs 50% in limited PLND). Finelli et al reported the feasibility and efficacy of laparoscopic ePLND [7] . The median number of nodes retrieved was 3 in the limited PLND group and 21
in the ePLND group. Indeed, laparoscopic cystectomy can be safely performed by a few highly skilled laparoscopic surgeons.
To overcome the technical difficulty of laparoscopic surgery, robot assistance was introduced as a way to shorten the learning curve. The use of robot assistance has been expanding in the field of radical cystectomy and PLND, especially ePLND. In a prospective study comparing robot-assisted radical cystectomy and laparoscopic radical cystectomy [29] , the mean number of LNs removed among RARC patients who had undergone ePLND was 22.3, whereas the mean number was 16.5 for the laparoscopic radical cystectomy patients. Guru et al reported the feasibility of robot-assisted ePLND with RARC in 67 patients; the mean number of LNs retrieved in that study was 18, and the frequency of patients with a LNY of ＞13 also increased overall with experience [10] . Also, robot-assisted PLND required a mean of 46 minutes, and 1 postoperative vascular complication occurred. Woods et al reported similar results [9] .
The mean total operative time of 27 patients undergoing RARC with ePLND was 400 minutes, and average blood loss was 277 ml. The mean number of LNs removed was 12.3. In our study, the difference between the operation time for ePLND and sPLND (106.7 vs 72.1 minutes) was significant (p=0.005).
However, the differences in mean estimated blood loss, total operative time, hospital stay, and time to flatus were not statistically significant. Our study has several limitations. First, most cases of extended dissection were performed during the late phase of this series. Because the authors did not experience pure laparoscopic pelvic surgery at the time of starting this series, sufficient experience to overcome the learning curve was required for the robot-assisted laparoscopic pelvic surgery.
Second, we cannot assess the recurrence-free survival and disease-free survival because of the short follow-up interval.
Similar outcomes for survival are expected, however, considering the previously mentioned literature. Because of these several limitations, more experiences are required to adequately evaluate and validate this procedure as an appropriate surgical and oncologic option for the management of bladder cancer.
CONCLUSIONS
Perioperative data and oncologic features suggest that RARC with PLND is feasible. From the viewpoint of PLND, especially ePLND, the robotic procedure is a safe and effective procedure with acceptable morbidity and good oncologic results, even when performed by a laparoscopy-naïve surgeon.
Large randomized controlled studies with long-term follow-up are required to confirm the oncologic results and survival benefit of this procedure.
